Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Centene Corp is a healthcare plans business based in the US. Centene shares (CNC) are listed on the NYSE and all prices are listed in US Dollars. Centene employs 72,500 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $84.61 |
|---|---|
| 52-week range | $59.67 - $89.92 |
| 50-day moving average | $82.45 |
| 200-day moving average | $77.84 |
| Wall St. target price | $96.00 |
| PE ratio | 32.7736 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $2.53 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $84.61 from 2022-06-30
| 1 week (2022-06-24) | 2.00% |
|---|---|
| 1 month (2022-06-01) | 4.19% |
| 3 months (2022-04-01) | -1.05% |
| 6 months (2021-12-31) | 2.68% |
| 1 year (2021-07-01) | 14.87% |
|---|---|
| 2 years (2020-07-01) | 29.35% |
| 3 years (2019-07-01) | 64.77% |
| 5 years (2017-06-30) | 5.92% |
Valuing Centene stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Centene's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Centene's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, Centene shares trade at around 33x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Centene's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0429. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Centene's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Centene's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.3 billion.
The EBITDA is a measure of a Centene's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $124.2 billion |
|---|---|
| Operating margin TTM | 3.08% |
| Gross profit TTM | $19.6 billion |
| Return on assets TTM | 3.12% |
| Return on equity TTM | 5.53% |
| Profit margin | 1.21% |
| Book value | $46.45 |
| Market capitalisation | $48.5 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Centene.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 28.72
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Centene's overall score of 28.72 (as at 12/31/2018) is pretty good – landing it in it in the 36th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Centene is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 5.14/100
Centene's environmental score of 5.14 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Centene is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 21.92/100
Centene's social score of 21.92 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Centene is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 10.66/100
Centene's governance score puts it squarely in the 7th percentile of companies rated in the same sector. That could suggest that Centene is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Centene scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Centene has, for the most part, managed to keep its nose clean.
Centene Corp was last rated for ESG on: 2019-01-01.
| Total ESG score | 28.72 |
|---|---|
| Total ESG percentile | 36.42 |
| Environmental score | 5.14 |
| Environmental score percentile | 7 |
| Social score | 21.92 |
| Social score percentile | 7 |
| Governance score | 10.66 |
| Governance score percentile | 7 |
| Level of controversy | 2 |
We're not expecting Centene to pay a dividend over the next 12 months.
Centene's shares were split on a 2:1 basis on 6 February 2019. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Centene shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Centene shares which in turn could have impacted Centene's share price.
Over the last 12 months, Centene's shares have ranged in value from as little as $59.67 up to $89.92. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Centene's is 0.5218. This would suggest that Centene's shares are less volatile than average (for this exchange).
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
